Our latest insights

The new rules will apply to individuals, trusts (which are not widely held) and to self-managed super funds (SMSF’s).

‘Presenteeism’ (the art of being at work but not working) happens in many businesses – it may very well be happening in yours right now.

The GST treatment of food products has made the headlines over the last few months. Most notably the above front page of The Age earlier this year.

According to industry best practice guidance in Australian Cyber Security Centre’s Essential Eight, a business's first step is to identify: what systems to protect, what information is likely to be targeted and how much protection is required.

Cybercrime does not discriminate by business size or industry. For a hacker to realise their ultimate goal – whether that be making money, stealing infrastructure, leveraging data to steal assets or boosting their ego – they want to find the easiest targets quickly.

Welcome to the 2019 edition of Bite Size Dealtracker Update which focuses on M&A and IPO activity in the Agribusiness, Food & Beverage industry in calendar year 2018. Our previous Bite Size Dealtrackers covered the 7 year period from 1 January 2011 to 31 December 2017 (Long Term Period).

There is an overlooked economic opportunity in Australia’s mid-sized businesses – with the right incentives and tax policies in place, they can grow in size, scale and reach. They can employ more people, collaborate with other Australian businesses, and better contribute to Australia’s bottom line.

Are you a property developer who has built new residential property to sell, but instead have had to lease them due to market conditions?

The Australian retail landscape is not only fascinating and dynamic, but highly prospective, with significant growth in the size of market forecast over the next five years.

The 2019 Biotechnology Industry Position survey conducted by Ausbiotech and supported by Grant Thornton has revealed that new technologies across regenerative medicine and medicinal cannabis are disrupting the industry, and Australia's global strength in clinical trials continues to drive contributions to the economic and social fabric of the country.

Financial reporting thresholds for ‘large’ proprietary companies have been doubled following a recent Australian legislative change which is effective for financial years commencing on or after 1 July 2019.

On 5 April 2019, the ATO released Draft Taxation Ruling, TR 2019/D2 to clarify how entities should utilise the ALDT (“the ALDT Draft Ruling”). This ruling applies retrospectively.